Duration and timing of bisphosphonate treatment as factors determining osteoblast mineralization
Background: Alendronate is a drug for the treatment of excessive bone resorption. Alendronate reduces osteoblast viability and mineralization in a dose-dependent manner. Other views of alendronate could affect mineralization. Therefore, the effects of timing and duration of alendronate treatment on...
Saved in:
| Main Author: | Somying Patntirapong |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2022-09-01
|
| Series: | Journal of Oral Biology and Craniofacial Research |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2212426822000884 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Timing of geranylgeraniol addition increases osteoblast activities under alendronate condition
by: Harikarn Mungpayabarn, et al.
Published: (2021-07-01) -
Treatment of bisphosphonate induced osteonecrosis of jaw in rats using an angiogenesis factor (A-Heal) and ABMDO (Autologous Bone Marrow Derived Osteoblasts)
by: Mir Sadat-Ali, et al.
Published: (2022-02-01) -
Treatment of patients with osteoporosis: issues of therapy duration, adherence, and replacement
by: N. V. Toroptsova
Published: (2018-12-01) -
The Potential of Enamel Matrix Derivative in Countering Bisphosphonate-Induced Effects in Osteoblasts
by: Minah Kim, et al.
Published: (2024-08-01) -
BISPHOSPHONATE TREATMENT AND ESOPHAGEAL DISEASE
by: Andrei Evgenyevich Karateyev
Published: (2010-09-01)